Get the Stockscreener App
14.84
3.82%
-0.59
After Hours:
14.83
-0.010
-0.07%
Hutchmed China Limited Adr Stock (HCM) Forecast
The Hutchmed China Limited Adr (HCM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.91, representing a +7.22% increase from the current price of $14.84. The highest analyst price target is $18.39, and the lowest is $13.44.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HCM Price Target
Average 22.16
(+49.34% Upside)
Is Hutchmed China Limited Adr (HCM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.26 | Neutral |
| STOCH(9,6) | 61.02 | Neutral |
| STOCHRSI(14) | 21.74 | Neutral |
| MACD(12,26) | 0.6346 | Buy |
| ADX(14) | 25.08 | Buy |
| William %R | -52.06 | Neutral |
| CCI(14) | -9.9019 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
16.33
Sell
|
16.02
Sell
|
| MA20 |
15.06
Buy
|
15.48
Buy
|
| MA50 |
14.51
Buy
|
14.93
Buy
|
| MA100 |
14.69
Buy
|
15.02
Buy
|
| MA200 |
15.97
Sell
|
15.57
Buy
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, HCM could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 3 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on HCM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.26 indicates that HCM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 61.02 indicates that HCM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 21.74 indicates that HCM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.08 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -9.9019 indicates that HCM is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HCM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Hutchmed China Limited Adr financial reports and earnings history, Hutchmed China Limited Adr (HCM) stock could reach $15.29 by 2030, $2.188 by 2040 and $7.7824 by 2050. See the projected annual prices until 2050 of the Hutchmed China Limited Adr stock below:
- Hutchmed China Limited Adr (HCM) is expected to reach an average price of $9.0405 in 2035, with a high prediction of $10.47 and a low estimate of $7.1285. This indicates an $-39.08% rise from the last recorded price of $14.84.
- Hutchmed China Limited Adr (HCM) stock is projected to chart a bullish course in 2040, with an average price target of $0.686, representing an $-95.38% surge from its current level. The forecast ranges from a conservative $0.104 to a sky-high $2.188.
- Our analysts predict Hutchmed China Limited Adr (HCM) to jump -7.37% by 2045, soaring from $10.17 to an average price of $13.75, potentially reaching $12.66. While $10.17 is the low estimate, the potential upside is significant.
- Hutchmed China Limited Adr (HCM) stock is expected to climb by 2050, reaching an average of $8.4224, a $-43.25% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.7824 and $2.0723, respectively, highlighting the market's uncertainty.
Hutchmed China Limited Adr Stock (HCM) Year by Year Forecast
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2025
Hutchmed China Limited Adr Stock (HCM) is expected to reach an average price of $18.52 in 2025, with a high prediction of $28.66 and a low estimate of $8.3739. This indicates an +24.78% rise from the last recorded price of $14.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $17.30 | $13.44 | $18.39 | +16.60% |
| August, 2025 | $22.17 | $17.28 | $23.21 | +49.38% |
| September, 2025 | $25.25 | $19.00 | $26.23 | +70.16% |
| October, 2025 | $28.28 | $24.25 | $28.66 | +90.58% |
| November, 2025 | $26.09 | $25.18 | $28.43 | +75.78% |
| December, 2025 | $23.26 | $22.58 | $28.40 | +56.71% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2026
The predicted value for Hutchmed China Limited Adr (HCM) in 2026 is set at an average of $27.84. Estimates vary from a peak of $38.01 to a trough of $17.67, indicating an +87.58% surge from the present price of $14.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $25.53 | $23.22 | $27.13 | +72.03% |
| February, 2026 | $22.20 | $20.95 | $25.64 | +49.62% |
| March, 2026 | $27.71 | $21.65 | $30.89 | +86.71% |
| April, 2026 | $27.72 | $24.57 | $30.66 | +86.78% |
| May, 2026 | $22.96 | $20.66 | $27.71 | +54.73% |
| June, 2026 | $23.21 | $20.25 | $23.40 | +56.37% |
| July, 2026 | $19.81 | $17.67 | $24.47 | +33.46% |
| August, 2026 | $24.57 | $19.42 | $24.99 | +65.56% |
| September, 2026 | $31.57 | $19.86 | $34.73 | +112.73% |
| October, 2026 | $35.95 | $29.97 | $38.01 | +142.28% |
| November, 2026 | $34.46 | $30.79 | $37.26 | +132.19% |
| December, 2026 | $30.69 | $29.80 | $37.03 | +106.79% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Hutchmed China Limited Adr (HCM) is $16.86, with a high forecast of $30.94 and a low forecast of $2.7665. This indicates an +13.58% increase from the last price of $14.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $26.31 | $25.52 | $30.94 | +77.30% |
| February, 2027 | $24.90 | $23.41 | $26.65 | +67.76% |
| March, 2027 | $29.18 | $22.25 | $30.56 | +96.60% |
| April, 2027 | $25.30 | $23.87 | $30.51 | +70.48% |
| May, 2027 | $21.07 | $18.89 | $26.00 | +42.01% |
| June, 2027 | $15.85 | $15.28 | $22.68 | +6.83% |
| July, 2027 | $13.23 | $8.7955 | $15.74 | -10.87% |
| August, 2027 | $10.33 | $10.31 | $15.31 | -30.38% |
| September, 2027 | $3.9215 | $2.7665 | $10.63 | -73.57% |
| October, 2027 | $5.4855 | $3.2795 | $6.3495 | -63.04% |
| November, 2027 | $9.9295 | $5.7115 | $10.07 | -33.09% |
| December, 2027 | $8.2995 | $6.0435 | $9.7355 | -44.07% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2028
In 2028, Hutchmed China Limited Adr (HCM) is projected to reach an average price of $8.8914, with a high projection of $15.88 and a low estimate of $1.9014. This indicates an -40.08% fall from the last price of $14.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.3634 | $6.4574 | $8.3855 | -50.38% |
| February, 2028 | $3.3474 | $2.8514 | $8.9654 | -77.44% |
| March, 2028 | $3.3574 | $1.9014 | $3.8634 | -77.38% |
| April, 2028 | $5.2514 | $2.9434 | $6.4254 | -64.61% |
| May, 2028 | $8.6014 | $5.5474 | $9.5814 | -42.04% |
| June, 2028 | $11.92 | $8.4174 | $12.84 | -19.71% |
| July, 2028 | $11.39 | $10.91 | $15.88 | -23.25% |
| August, 2028 | $8.8494 | $7.8994 | $12.25 | -40.37% |
| September, 2028 | $9.3233 | $6.9933 | $9.7813 | -37.17% |
| October, 2028 | $10.63 | $8.7993 | $12.83 | -28.39% |
| November, 2028 | $7.2273 | $6.3891 | $10.81 | -51.30% |
| December, 2028 | $6.7513 | $5.4253 | $9.0093 | -54.51% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2029
The 2029 price forecast for Hutchmed China Limited Adr Stock (HCM) is $11.52 on average, with a high prediction of $16.69 and a low estimate of $6.3573. This represents an -22.35% decrease from the previous price of $14.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.8513 | $6.3573 | $9.7553 | -40.36% |
| February, 2029 | $9.1053 | $7.8793 | $11.30 | -38.64% |
| March, 2029 | $9.5393 | $8.6033 | $10.87 | -35.72% |
| April, 2029 | $13.52 | $10.06 | $13.74 | -8.87% |
| May, 2029 | $13.90 | $11.08 | $15.60 | -6.31% |
| June, 2029 | $13.47 | $12.24 | $14.59 | -9.25% |
| July, 2029 | $13.04 | $11.68 | $14.73 | -12.12% |
| August, 2029 | $7.4612 | $7.3783 | $12.74 | -49.72% |
| September, 2029 | $10.71 | $6.9075 | $11.19 | -27.86% |
| October, 2029 | $11.41 | $8.6432 | $14.41 | -23.15% |
| November, 2029 | $11.54 | $11.11 | $13.17 | -22.24% |
| December, 2029 | $12.06 | $11.74 | $16.69 | -18.73% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2030
Hutchmed China Limited Adr Stock (HCM) is expected to reach an average price of $9.4897 in 2030, with a high forecast of $17.01 and a low forecast of $1.9677. This signifies an -36.05% decrease from the last price of $14.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.04 | $9.812 | $15.29 | -12.13% |
| February, 2030 | $8.7579 | $7.516 | $16.80 | -40.98% |
| March, 2030 | $6.8959 | $6.1019 | $9.2399 | -53.53% |
| April, 2030 | $8.4789 | $6.0249 | $8.9989 | -42.86% |
| May, 2030 | $4.7739 | $3.4068 | $9.0679 | -67.83% |
| June, 2030 | $6.9119 | $3.8679 | $7.8619 | -53.42% |
| July, 2030 | $10.89 | $5.7938 | $10.99 | -26.64% |
| August, 2030 | $12.62 | $9.2198 | $12.75 | -14.96% |
| September, 2030 | $13.57 | $11.28 | $13.90 | -8.57% |
| October, 2030 | $15.54 | $9.5738 | $17.01 | +4.70% |
| November, 2030 | $7.3657 | $5.6757 | $15.64 | -50.37% |
| December, 2030 | $5.0737 | $1.9677 | $7.0997 | -65.81% |
0.98%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):